EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRW and the CUSIP is G3141W122. A total of 27 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,205 | -99.6% | 33,333 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $332,997 | -0.3% | 33,333 | 0.0% | 0.01% | +37.5% |
| Q3 2022 | $334,000 | +1.2% | 33,333 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $330,000 | +0.3% | 33,333 | 0.0% | 0.01% | +14.3% |
| Q1 2022 | $329,000 | +1.2% | 33,333 | 0.0% | 0.01% | -22.2% |
| Q4 2021 | $325,000 | -0.3% | 33,333 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $326,000 | -0.6% | 33,333 | 0.0% | 0.01% | -10.0% |
| Q2 2021 | $328,000 | -1.5% | 33,333 | 0.0% | 0.01% | -23.1% |
| Q1 2021 | $333,000 | -0.6% | 33,333 | 0.0% | 0.01% | -38.1% |
| Q4 2020 | $335,000 | – | 33,333 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 66,666 | $660,000 | 0.02% |
| Radcliffe Capital Management, L.P. | 33,333 | $330,000 | 0.01% |
| Altium Capital Management LP | 133,333 | $9,000 | 0.00% |
| Arena Investors LP | 94,516 | $6,000 | 0.00% |
| Granite Point Capital Management, L.P. | 133,332 | $9,000 | 0.00% |
| COWEN AND COMPANY, LLC | 122,257 | $8,000 | 0.00% |
| 683 Capital Management, LLC | 200,000 | $13,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GLAZER CAPITAL, LLC | 11,584 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 26,666 | $2,000 | 0.00% |